1415566-32-3

Basic information

• Product Name: (R)-1-(tert-butoxycarbonyl)-2-Methylpiperidine-2-carboxylic acid
• Synonyms: (R)-1-(tert-butoxycarbonyl)-2-Methylpiperidine-2-carboxylic acid;(2R)-1-[(tert-butoxy)carbonyl]-2-methylpiperidine-2-carboxylic acid
• CAS NO: 1415566-32-3
• Molecular Formula: C12H21NO4
• Molecular Weight: 243.29944
• Mol File: 1415566-32-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (R)-1-(tert-butoxycarbonyl)-2-Methylpiperidine-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-1-(tert-butoxycarbonyl)-2-Methylpiperidine-2-carboxylic acid(1415566-32-3)
• EPA Substance Registry System: (R)-1-(tert-butoxycarbonyl)-2-Methylpiperidine-2-carboxylic acid(1415566-32-3)

Safety Data

• Hazardous Substances Data: 1415566-32-3(Hazardous Substances Data)

Usage

Description

(R)-1-(tert-butoxycarbonyl)-2-Methylpiperidine-2-carboxylic acid is a chemical compound with the molecular formula C14H23NO4, belonging to the piperidine class of compounds. It features a carboxylic acid group and a tert-butoxycarbonyl protecting group, which contribute to its potential applications in organic synthesis and pharmaceutical research.

Uses

Used in Organic Synthesis:
(R)-1-(tert-butoxycarbonyl)-2-Methylpiperidine-2-carboxylic acid is used as a building block for the synthesis of complex molecules, due to its versatile chemical structure and the presence of a carboxylic acid group.
Used in Pharmaceutical Research:
(R)-1-(tert-butoxycarbonyl)-2-Methylpiperidine-2-carboxylic acid is used as a starting material or intermediate in the development of new drugs, particularly in the pharmaceutical industry, because of its potential to be modified and incorporated into various drug candidates.
Used in Chemical Synthesis:
(R)-1-(tert-butoxycarbonyl)-2-Methylpiperidine-2-carboxylic acid is used as a valuable tool for chemical synthesis, thanks to the tert-butoxycarbonyl protecting group that allows for controlled and selective reactions in the synthesis of target molecules.
Overall, (R)-1-(tert-butoxycarbonyl)-2-Methylpiperidine-2-carboxylic acid has a wide range of potential applications across the chemical and pharmaceutical industries, making it a compound of interest for researchers and synthetic chemists.

Upstream product

• 124-38-9 carbon dioxide 
• 746658-72-0 2-cyano-2-methylpiperidine-1-carboxylic acid tert-butyl ester 
• 42457-10-3 piperidine-2-carbonitrile 
• 24424-99-5 di-tert-butyl dicarbonate 
• 153749-89-4 2-cyanopiperidine-1-carboxylic acid tert-butyl ester 
• 98303-20-9 1-(tert-butoxycarbonyl)piperidine-2-carboxylic acid 
• 74-88-4 methyl iodide 

Relevant articles and documents

Generation and utility of tertiary α-aminoorganolithium reagents

A general approach to tertiary α-aminoorganolithium reagents by reductive lithiation of α-aminonitriles has been developed. This class of organolithium nucleophiles reacts efficiently with carbonyl electrophiles or in intramolecular cyclizations with teth

CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF

The present invention is directed to cytotoxic pentapeptides, to antibody drug conjugates thereof, and to methods for using the same to treat cancer.

Vanilloid receptor ligands and their use in treatments

Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.